CM
BRLI

CS McKee’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

CS McKee’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-225,765
Closed -$9.31M – 108
2015
Q2 		$9.31M Sell
225,765
-6,250
-3% -$224K 0.26% 70
2015
Q1 		$8.18M Sell
232,015
-32,810
-12% -$1.11M 0.21% 73
2014
Q4 		$8.51M Sell
264,825
-130,015
-33% -$3.76M 0.21% 77
2014
Q3 		$11.1M Sell
394,840
-65,620
-14% -$2M 0.25% 76
2014
Q2 		$13.9M Sell
460,460
-45,220
-9% -$1.25M 0.29% 77
2014
Q1 		$14M Sell
505,680
-45,600
-8% -$1.19M 0.3% 81
2013
Q4 		$14.1M Sell
551,280
-388,890
-41% -$12M 0.28% 82
2013
Q3 		$28.1M Buy
940,170
+397,820
+73% +$11.1M 0.48% 63
2013
Q2 		$15.6M Buy
+542,350
New +$14.9M 0.27% 95

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

CS McKee's BRLI Position: Q3 2015 in Review

CS McKee sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 225,765 shares — an estimated $9.31M sold.

CS McKee first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $28.1M in Q3 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • CS McKee reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • CS McKee sold 225,765 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $9.31M.
  • CS McKee first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • CS McKee's BIO-REFERENCE LABS INC-NEW- position peaked at $28.1M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on CS McKee's 13F filing for Q3 2015, filed 13 Nov 2015.